HKD3.81
5.69% yesterday
Hong Kong, Nov 15, 08:47 am CET
ISIN
BMG0171K1018
Symbol
0241
Index
Sector
Industry

Alibaba Health Information Technology Target price 2024 - Analyst rating & recommendation

Alibaba Health Information Technology Classifications & Recommendation:

Buy
75%
Hold
17%
Sell
8%

Alibaba Health Information Technology Price Target

Target Price HKD4.56
Price HKD3.80
Potential
Number of Estimates 10
10 Analysts have issued a price target Alibaba Health Information Technology 2025 . The average Alibaba Health Information Technology target price is HKD4.56. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 9 Analysts recommend Alibaba Health Information Technology to buy, 2 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Alibaba Health Information Technology stock has an average upside potential 2025 of . Most analysts recommend the Alibaba Health Information Technology stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '24 2025
Estimates
Revenue Billion HKD 29.49 32.76
3.63% 11.10%
EBITDA Margin 2.55% 5.52%
3,569.45% 116.61%

11 Analysts have issued a sales forecast Alibaba Health Information Technology 2025 . The average Alibaba Health Information Technology sales estimate is

HKD32.8b
Unlock
. This is
6.62% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD34.7b 12.97%
Unlock
, the lowest is
HKD31.9b 3.77%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 HKD29.5b 3.63%
2025
HKD32.8b 11.10%
Unlock
2026
HKD36.8b 12.24%
Unlock
2027
HKD40.9b 11.33%
Unlock
2028
HKD43.8b 6.98%
Unlock

8 Analysts have issued an Alibaba Health Information Technology EBITDA forecast 2025. The average Alibaba Health Information Technology EBITDA estimate is

HKD1.8b
Unlock
. This is
38.70% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
HKD2.0b 52.18%
Unlock
, the lowest is
HKD1.5b 13.27%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 HKD751m 3,436.33%
2025
HKD1.8b 140.60%
Unlock
2026
HKD2.5b 36.20%
Unlock
2027
HKD3.1b 26.04%
Unlock
2028
HKD4.2b 36.05%
Unlock

EBITDA Margin

2024 2.55% 3,569.45%
2025
5.52% 116.61%
Unlock
2026
6.70% 21.38%
Unlock
2027
7.58% 13.13%
Unlock
2028
9.64% 27.18%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '24 2025
Estimates
Earnings Per Share HKD 0.07 0.12
40.00% 71.43%
P/E 32.84
EV/Sales 1.59

5 Analysts have issued a Alibaba Health Information Technology forecast for earnings per share. The average Alibaba Health Information Technology <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

HKD0.12
Unlock
. This is
50.00% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
HKD0.12 50.00%
Unlock
, the lowest is
HKD0.11 37.50%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 HKD0.07 40.00%
2025
HKD0.12 71.43%
Unlock
2026
HKD0.15 25.00%
Unlock
2027
HKD0.20 33.33%
Unlock
2028
HKD0.24 20.00%
Unlock

P/E ratio

Current 45.08 57.21%
2025
32.84 27.15%
Unlock
2026
25.26 23.08%
Unlock
2027
18.68 26.05%
Unlock
2028
15.88 14.99%
Unlock

Based on analysts' sales estimates for 2025, the Alibaba Health Information Technology stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.70 1.19%
2025
1.59 6.24%
Unlock
2026
1.42 10.90%
Unlock
2027
1.28 10.17%
Unlock
2028
1.19 6.53%
Unlock

P/S ratio

Current 1.99 4.97%
2025
1.86 6.20%
Unlock
2026
1.66 10.91%
Unlock
2027
1.49 10.17%
Unlock
2028
1.39 6.53%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today